Advancing Healthcare
through Innovation
e·merge /əˈmərj/ to become apparent, important or prominent
e-merge is a venture capital and growth equity firm committed to investing in innovative medical device companies and technologies that enhance patient outcomes and improve quality of life
e·merge /əˈmərj/ to become apparent, important or prominent
Access
Our business and physician advisors provide best-in-class expertise to assist with evaluating and de-risking new opportunities and supporting our portfolio companies.
Experience
e-merge brings decades of collective experience in medical devices, business and venture capital investing.
We have solved many of the challenges faced by early-stage medical device companies and understand how strategic buyers and partners think.
Network
Through our network, we leverage trusted relationships with vendors, consultants, investors and strategic medical device companies.
E-merge Capital Partners Launches Venture Capital Fund Dedicated to Early-Stage Medical Device Products and Companies
May 19, 2021 — E-merge Capital Partners (E-merge) today announced the first closing of investments in its venture fund (E-merge Fund I) focused on early-stage medical device companies and technologies.
The E-merge team brings decades of medical device and venture investing experience, as well as diverse entrepreneurial backgrounds, to the new venture. The firm will be led by Managing Partners Brad Klos and John M. Xitco, and Venture Partners Randy Werneth and Rob Abrams. Read more…
News & Recent Events
